Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine

American Journal of Transplantation

Volumn 12, Issue 1, 2012, Pages 218-225

  Hofbauer, G F L ^a   Attard, N R ^b   Harwood, C A ^c   McGregor, J M ^c   Dziunycz, P ^a   Iotzova Weiss, G ^a   Straub, G ^a   Meyer, R ^a   Kamenisch, Y ^d   Berneburg, M ^d   French, L E ^a   Wuthrich R P ^e   Karran, P ^b   Serra, A L ^e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

6 thioguanine DNA; Azathioprine; kidney transplantation; skin photosensitivity; UVA

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN P53; TIOGUANINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DNA CONTENT; DNA DAMAGE; DRUG SAFETY; ERYTHEMA; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTODERMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SKIN PHOTOSENSITIVITY; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

AZATHIOPRINE; DNA DAMAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PHOTOSENSITIZING AGENTS; SKIN; ULTRAVIOLET RAYS;

EID: 84855922569     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03751.x     Document Type: Article

References (26)

1. Euvrard S, Kanitakis J, Claudy A,. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691. (Pubitemid 36459475)
2. Wu X, Nguyen BC, Dziunycz P, et al,. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 2010; 465: 368-372.
3. Hofbauer GF, Bouwes Bavinck JN, Euvrard S,. Organ transplantation and skin cancer: Basic problems and new perspectives. Exp Dermatol 2010; 19: 473-482.
4. Lankerani L, Baron ED,. Photosensitivity to exogenous agents. J Cutan Med Surg 2004; 8: 424-431. (Pubitemid 41414111)
5. Moore DE,. Drug-induced cutaneous photosensitivity: Incidence, mechanism, prevention and management. Drug Saf 2002; 25: 345-372. (Pubitemid 34634272)
6. Relling MV, Dervieux T,. Pharmacogenetics and cancer therapy. Nat Rev Cancer 2001; 1: 99-108. (Pubitemid 33741885)
7. O'Donovan P, Perrett CM, Zhang X, et al,. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-1874. (Pubitemid 41325100)
8. Kelly GE, Meikle W, Sheil AG,. Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 1987; 44: 429-434. (Pubitemid 17142055)
9. Perrett CM, Walker SL, O'Donovan P, et al,. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol 2008; 159: 198-204. (Pubitemid 351874494)
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
11. Fitzpatrick TB,. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
12. Muehleisen B, Schaerer L, Dummer R, Burg G, Hofbauer GF,. Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. J Cutan Pathol 2007; 34: 1-6. (Pubitemid 46066519)
13. Jensen AO, Thomsen HF, Engebjerg MC, Olesen AB, Sorensen HT, Karagas MR,. Use of photosensitising diuretics and risk of skin cancer: A population-based case-control study. Br J Cancer 2008; 99: 1522-1528.
14. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S,. Skin cancer in organ transplant recipients-where do we stand today? Am J Transplant 2008; 8: 2192-2198.
15. Brem R, Li F, Karran P,. Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions. Nucleic Acids Res 2009; 37: 1951-1961.
16. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN,. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003; 120: 1087-1093. (Pubitemid 36702922)
17. Young AR, Potten CS, Nikaido O, et al,. Human melanocytes and keratinocytes exposed to UVB or UVA in vivo show comparable levels of thymine dimers. J Invest Dermatol 1998; 111: 936-940. (Pubitemid 29115157)
18. Hacham H, Freeman SE, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM,. Do pyrimidine dimer yields correlate with erythema induction in human skin irradiated in situ with ultraviolet light (275-365 nm)? Photochem Photobiol 1991; 53: 559-563.
19. Freeman SE, Hacham H, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM,. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci U S A 1989; 86: 5605-5609. (Pubitemid 19185593)
20. Yamaizumi M, Sugano T,. U.V.-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. Oncogene 1994; 9: 2775-2784. (Pubitemid 24296751)
21. Al-Tassan N, Chmiel NH, Maynard J, et al,. Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors. Nat Genet 2002; 30: 227-232.
22. Nguyen T, Vacek PM, O'Neill P, Colletti RB, Finette BA,. Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease. Cancer Res 2009; 69: 7004-7012.
23. Harwood CA, Attard NR, O'Donovan P, et al,. PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. Br J Cancer 2008; 99: 1276-1284.
24. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD,. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54: 1121-1125. (Pubitemid 41025906)
25. Armstrong RG, West J, Card TR,. Risk of cancer in inflammatory bowel disease treated with azathioprine: A UK population-based case-control study. Am J Gastroenterol 2010; 105: 1604-1609.
26. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE,. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249-1252. (Pubitemid 24158045)